Bogart Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.1K Buy
31
+9
+41% +$6.8K ﹤0.01% 782
2026
Q2
$13.7K Buy
22
+2
+10% +$1.36K ﹤0.01% 916
2026
Q1
$15.5K Buy
20
+4
+25% +$3.06K ﹤0.01% 787
2025
Q4
$12.4K Buy
16
+1
+7% +$679 ﹤0.01% 816
2025
Q3
$8.43K Buy
15
+3
+25% +$1.7K ﹤0.01% 864
2025
Q2
$6.3K Sell
12
-17
-59% -$9.49K ﹤0.01% 887
2025
Q1
$18.4K Buy
29
+1
+4% +$688 ﹤0.01% 606
2024
Q4
$19.9K Hold
28
– – ﹤0.01% 586
2024
Q3
$29.4K Hold
28
– – ﹤0.01% 493
2024
Q2
$29.4K Hold
28
– – ﹤0.01% 478
2024
Q1
$27K Hold
28
– – ﹤0.01% 465
2023
Q4
$24.6K Sell
28
-8
-22% -$6.59K ﹤0.01% 473
2023
Q3
$29.6K Hold
36
– – ﹤0.01% 419
2023
Q2
$25.9K Buy
36
+6
+20% +$4.63K ﹤0.01% 422
2023
Q1
$24.6K Sell
30
-6
-17% -$4.52K ﹤0.01% 424
2022
Q4
$26K Buy
36
+11
+44% +$8.12K ﹤0.01% 391
2022
Q3
$17K Hold
25
– – ﹤0.01% 461
2022
Q2
$15K Hold
25
– – ﹤0.01% 469
2022
Q1
$17K Hold
25
– – ﹤0.01% 415
2021
Q4
$16K Hold
25
– – ﹤0.01% 409
2021
Q3
$15K Hold
25
– – ﹤0.01% 402
2021
Q2
$14K Hold
25
– – ﹤0.01% 396
2021
Q1
$12K Buy
+25
New +$12.2K ﹤0.01% 392

Other funds holding REGN

Bogart Wealth's REGN Position: Q3 2026 in Review

Bogart Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 41% in Q3 2026, buying an estimated $6.8K and bringing the position to 31 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Bogart Wealth first reported a position in REGN in Q1 2021 and has held it in 23 quarters since. The position peaked at $29.6K in Q3 2023. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Bogart Wealth held 31 shares of Regeneron Pharmaceuticals worth $23.1K as of Q3 2026.
  • Bogart Wealth bought 9 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $6.8K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #782 holding.
  • Bogart Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 23 quarters since.
  • Bogart Wealth's Regeneron Pharmaceuticals position peaked at $29.6K in Q3 2023.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.